SC
GRTS

Shay Capital’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Shay Capital’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,494
Closed -$43.1K – 534
2022
Q4 		$43.1K Buy
+12,494
New +$35.7K 0.01% 231

Other funds holding GRTS

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Shay Capital's GRTS Position: Q1 2023 in Review

Shay Capital sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q1 2023, closing a stake of 12,494 shares — an estimated $43.1K sold.

Shay Capital first reported a position in GRTS in Q4 2022 and held it in 1 quarter. The position peaked at $43.1K in Q4 2022. 90 funds tracked by Wall St. Rank hold GRTS as of Q1 2023.

  • Shay Capital reported no remaining Gritstone bio, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Shay Capital sold 12,494 Gritstone bio, Inc. Common Stock shares in Q1 2023, an estimated $43.1K.
  • Shay Capital first reported a position in Gritstone bio, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Shay Capital's Gritstone bio, Inc. Common Stock position peaked at $43.1K in Q4 2022.
  • 90 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q1 2023.

Based on Shay Capital's 13F filing for Q1 2023, filed 15 May 2023.